Cytokine-mediated antitumor effect of OK-432 on urinary bladder tumor cells in vitro

Urological Research

Volumn 25, Issue 4, 1997, Pages 239-245

  Sakano, Shigeru ^a   Shimabukuro, Tomoyuki ^a   Ohmoto, Yasukazu ^b   Naito, Katsusuke ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Cytokine; Human bladder cancer cells; In vitro; OK 432

Indexed keywords

BCG VACCINE; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOMODULATING AGENT; INTERFERON ANTIBODY; INTERLEUKIN 1BETA; MONOCLONAL ANTIBODY; PICIBANIL; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CARCINOMA, TRANSITIONAL CELL; CELL DIVISION; CULTURE MEDIA, CONDITIONED; CYTOKINES; DRUG INTERACTIONS; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LEUKOCYTES, MONONUCLEAR; PICIBANIL; TIME FACTORS; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0030826893     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00942092     Document Type: Article

References (29)

1. Böhle A, Nowc Ch, Ulmer AJ, Musehold J, Gerdes J, Hofstetter AG, Flad HD (1990) Elevations of cytokines interleukin-1, interleukin-2 and tumor necrosis factor in the urine of patients after intravesical bacillus Calmette-Guérin immunotherapy. J Urol 144:59
2. Bubenik J, Baresova M, Viklicky V, Jakoubkova J, Sainerova H, Donner J (1973) Established cell line of urinary bladder carcinoma (T24) containing tumor-specific antigen. Int J Cancer 11:765
3. Fujita K (1987) The role of adjunctive immunotherapy in superficial bladder cancer. Cancer 59:2027
4. Geboers ADH, van Bergen TNLM, Oosterlinck W (1987) Gamma-interferon in the therapeutic and prophylactic management of superficial bladder cancer (abstract 691). J Urol [Part 2] 137:276A
5. Ham RG (1972) Cloning of mammalian cells. In: Prescott DM (ed) Methods in cell physiology, vol V. Academic Press, New York, p 37
6. Herr HW, Landone VP, Whitmore WF (1987) An overview of intravesical therapy for superficial bladder tumors. J Urol 138:1363
7. Kagawa S, Ogura K, Kurokawa K, Uyama K (1979) Immunological evaluation of a streptococcal preparation (OK-432) in treatment of bladder carcinoma. J Urol 122:467
8. Kagawa S (1976) Experimental studies of effects of the streptococcal anticancer preparation (Picibanil) for bladder carcinomas of ACI/N rats. Jpn J Urol 67:73
9. Kawaguchi T, Suematsu M, Koizumi HM, Mitsui H, Suzuki S, Matsuno T, Ogawa H, Nomoto K (1983) Activation of macrophage function by intraperitoneal administration of the streptococcal antitumor agent OK-432. Immunopharmacology 6:177
10. Kurisu H, Matsuyama H, Ohmoto Y, Shimabukuro T, Naito K (1994) Cytokine-mediated antitumor effect of bacillus Calmette-Guérin on tumor cells in vitro. Cancer Immunol Immunother 39:249
11. Lamm DL, Stogdill VD, Stogdill BJ, Crispen RG (1986) Complication of bacillus Calmette-Guérin immunotherapy in 1,278 patients with bladder cancer. J Urol 135:272
12. Mizutani Y, Nio Y, Yoshida O (1992) Effects of bacillus Calmette-Guérin on cytotoxic activities of peripheral blood lymphocytes against human T24 lined and freshly separated autologous urinary bladder transitional carcinoma cells in patients with urinary bladder cancer. Cancer 69:537
13. Mizutani Y, Nio Y, Yoshida O (1992) The streptococcal preparation OK-432 specifically augments the susceptibility of human urinary bladder tumor cells to autologous peripheral blood lymphocytes. Cancer 69:2999
14. Morales A, Eidinger D, Bruce AW (1976) Intracavitary bacillus Calmette-Guérin in the treatment of superficial bladder tumors. J Urol 116:180
15. Nio Y, Zighelboim J, Berek J, Bonavida B (1989) Cytotoxic and cytostatic effects of the streptococcal preparation OK-432 and its subcellular fractions on human ovarian tumor cells. Cancer 64:434
16. Ohigashi T, Tachibana M, Tazaki H, Nakamura K (1992) Bladder cancer cells express functional receptors for granulocyte-colony stimulating factor. J Urol 147:283
17. Onozaki K, Matsushima K, Aggarwal BB, Oppenheim JJ (1985) Human interleukin 1 is a cytocidal factor for several tumor cell lines. J Immunol 135:3962
18. Prescott S, James K, Hargreave TB, Chisholm GD, Smyth JF (1990) Radio-immunoassay detection of interferon-gamma in urine after intravesical Evans BCG therapy. J Urol 144:1248
19. Ruggiero V, Baglioni C (1987) Synergistic anti-proliferative activity of interleukin 1 and tumor necrosis factor. J Immunol 138:661
20. Saito M, Ichimura O, Kataoka M, Moriya Y, Ueno K, Sugawara Y, Nanjo M, Ishida N (1986) Pronounced antitumor effect of mice after intraperitoneal injection of OK-432, a killed streptococcal preparation. Cancer Immunol Immunother 22:161
21. Segawa K, Ueno Y, Kataoka T (1991) In vivo tumor growth enhancement by granulocyte colony-stimulating factor. Jpn J Cancer Res 82:440
22. Shameem IA, Kurisu H, Matsuyama H, Shimabukuro T, Naito K (1994) Direct and indirect effects of recombinant human granulocyte colony-stimulating factor on in vitro colony formation of human bladder cancer cells. Cancer Immunol Immunother 38:353
23. Studer UE, Casanova G, Kraft R, Zingg EJ (1989) Percutaneous bacillus Calmette-Guérin perfusion of the upper urinary tract for carcinoma in situ. J Urol 142:975
24. Sugarman BJ, Aggarwal BB, Hass PE, Figari IS, Pallandino Jr MA, Shepard HM (1985) Recombinant human tumor necrosis factor-α: effects on proliferation of normal and transformed cells in vitro. Science 230:943
25. Tanaka K, Ishikawa E, Ohmoto Y, Hirai Y (1987) In vitro production of human interleukin 1α and interleukin 1β by peripheral blood mononuclear cells examined by sensitive sandwich enzyme immunoassay. Eur J Immunol 17:1527
26. Taya T, Kobayashi T, Tsukahara K, Uchibayashi T, Naito K, Hisazumi H, Kuroda K (1977) In vitro culture of malignant tumor tissues from the human urinary tract. Jpn J Urol 68:1003
27. Torisu M, Katano M, Kimura Y, Itoh H, Takesue M (1983) New approach to management of malignant ascites with a streptococcal preparation, OK-432. I. Improvement of host immunity and prolongation of survival Surgery 93:357
28. Uchida A, Micksche M (1983) Intrapleural administration of OK-432 in cancer patients:activation of NK cells and reduction of suppressor cells. Int J Cancer 31:1
29. Wakasugi H, Kasahara T, Minato N, Hamuro J, Miyata M, Morioka Y (1982) In vitro potentiation of human natural killer cell activity by a streptococcal preparation, OK-432: interferon and interleukin-2 participation in the stimulation with OK-432. J Natl Cancer Inst 69:807